Clinical Trial

High-Dose Vitamin D Supplementation and Exercise Effects on Vitamin D Metabolites in Professional Football Players

Study acronym: VitD-Football
Completed
View on ClinicalTrials.gov →
Summary
This randomized, single-blind, placebo-controlled pilot study investigated the effects of high-dose vitamin D₃ supplementation and football-specific physical exercise on vitamin D metabolite concentrations in professional male football players. The study aimed to evaluate the acute response of circulating vitamin D metabolites, including 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃, following a single oral dose of 500,000 IU cholecalciferol combined with high-intensity intermittent exercise typical of competitive football. Twenty professional football players from a Polish top-division club participated in the study. Participants were randomly assigned to either the supplementation group (SGP) receiving 500,000 IU of vitamin D₃ or the placebo group (PGP) receiving an identical volume of placebo oil. The intervention was administered 48 hours prior to an intra-squad game. Blood samples were collected at three time points: baseline (T3), pre-match (T4), and post-match (T5). The primary outcome was the change in serum 25-(OH)D₃ concentration. Secondary outcomes included changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, as well as their ratios. The study also assessed whether physical exercise modulates vitamin D metabolism. The findings demonstrated that high-dose vitamin D₃ supplementation significantly increased serum 25-(OH)D₃ (↑198%) and 3-epi-25-(OH)D₃ (↑444%) levels, while football-specific exercise itself induced moderate increases in vitamin D metabolites. The results suggest that skeletal muscle may play a key role in vitamin D storage and release in response to exercise. The supplementation was well tolerated, with no adverse events observed.
Trial Details
NCT Number NCT07310329
Lead Sponsor Wroclaw University of Health and Sport Sciences
Conditions Vitamin D Deficiency (10 ng/mL to 30 ng/mL), Athletes, Football Players, Exercise Physiology
Enrollment 20 participants
Start Date 2024-04-27
Primary Completion 2024-05-17 (estimated)
Study Completion 2024-06-24 (estimated)
Updated on ClinicalTrials.gov 2025-12-30